The Spectranetics Earnings Preview: Get Ahead of the Analysts

The Spectranetics (NASDAQ:SPNC) will report earnings before markets open on Wednesday, July 24th. The Spectranetics Corporation develops, manufactures, markets, and distributes its technology for interventional cardiovascular therapy. The Company’s CVX-300 excimer laser system is used in applications such as coronary angioplasty and the removal of pacemaker leads. Spectranetics is also developing other applications in restenosis stents and peripheral vascular applications.

Here is your Cheat Sheet to The Spectranetics Earnings:

Earnings Expectations: Analysts expect earnings of $-0.02 per share on revenues of $38.69 million. Currently, the company’s P/E ratio stands at 630.67.

Analyst Trends:

Analysts have a neutral outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings is a profit of $0.01 and has not changed. For the current year, the average estimate is a loss of $0.01, which is worse than the estimate ninety days ago.

Earnings Trends:

Here’s how The Spectranetics has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 104 115 118 127 140
Diluted EPS ($) -0.12 -0.41 -0.40 0.03 0.06

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012 Mar. 31, 2013
Revenue ($) in millions 35.03 35.23 36.75 37.67
Diluted EPS ($) 0.02 0.03 0.02 -0.03

Past Performance:
The Spectranetics has beat analyst estimates 2 times in the past four quarters. This is not consistent enough to get bullish yet.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]